Answers are grounded in this paper and cite their sources.
The troponin I (TnI) inhibitory region (residues 104-115) was synthesized with alpha-14C-labeled Gly-104 and a covalently linked benzoylbenzoyl (BB) moiety at the N terminus to yield a photoactivatable radioactive peptide (BBIp). BBIp was cross-linked to rabbit skeletal muscle troponin C (TnC) to locate the binding site on TnC. The TnC/BBIp mixture was subjected to photolysis in aqueous buffer at pH 7.5 in the presence or absence of Ca2+. A covalent (1:1) cross-linked protein-peptide complex (TnC.BBIp) was isolated in both cases. The cross-linked complex was digested with trypsin, and the peptide fragments were separated by reversed-phase high performance liquid chromatography. The radioactive cross-linked peptide was isolated and further characterized by peptide sequencing and mass spectrometry before and after cyanogen bromide cleavage. The results indicated that Met-155 of TnC was cross-linked to the BB moiety of BBIp in either the presence or absence of Ca2+. The biological activity of both the BBIp peptide and the cross-linked TnC.BBIp complex was studied and a model of the TnC.inhibitory peptide complex was derived using molecular dynamic and energy minimization calculations.
No takes yet. Share an insight, caveat, or question.
Ngai et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: